Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • INFECTIOUS AETIOLOGY OF MARGINAL ZONE LYMPHOMA AND ROLE OF ANTI-INFECTIVE THERAPY

    Salvatore Perrone, Gianna Maria D'Elia, Alessandro Pulsoni
    e2016006
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.006
    4529
    PDF: 1377
    HTML: 2187
  • Coexisting Pulmonary Tuberculosis and Mucormycosis in a Patient with Aplastic Anemia Post Allogenic Stem Cell Transplantion

    Sanjeev Kumar Sharma, Narendra Agrawal, Anjan Mukherjee, Tulika Seth, Pravas Mishra, Immaculata Xess, Manoranjan Mahapatra, Sanjay Sharma
    e2011036
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.036
    2796
    PDF: 725
    HTML: 897
  • THE BROAD-RANGING PANORAMA OF SYSTEMIC AUTOINFLAMMATORY DISORDERS WITH SPECIFIC FOCUS ON ACUTE PAINFUL SYMPTOMS AND HEMATOLOGIC MANIFESTATIONS IN CHILDREN

    Donato Rigante
    e2018067
    2018-10-30
    https://doi.org/10.4084/mjhid.2018.067
    2166
    PDF: 1332
    HTML: 973
  • SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW

    Francesca Pavanello, Sara Steffanoni, Michele Ghielmini, Emanuele Zucca
    e2016062
    2016-11-06
    https://doi.org/10.4084/mjhid.2016.062
    3855
    PDF: 1092
    HTML: 2440
  • APLASTIC ANEMIA AND VIRAL HEPATITIS

    Laura Cudillo
    e2009026
    https://doi.org/10.4084/mjhid.2009.026
    1304
    PDF: 539
    HTML: 23124
  • NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL

    Dimitar Efremov, Adrian Wiestner, Luca Laurenti
    e2012067
    2012-10-09
    https://doi.org/10.4084/mjhid.2012.067
    2604
    PDF: 871
    HTML: 9052
    Efremov 1: 249
    Efremov 2: 211
  • THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association

    Katia Paciaroni, Selenia Campagna, Nicoletta Villiva', Enrico Maffini, Francesca Celesti, Attilio Tordi, Mariangela Lombardi, Giulia Dragonetti, Tommaso Caravita di Toritto
    e2025023
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.023
    1120
    PDF: 1237
    HTML: 116
  • TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL

    Giorgia Sulis, Alberto Roggi, Alberto Matteelli, Mario C. Raviglione
    e2014070
    2014-10-27
    https://doi.org/10.4084/mjhid.2014.070
    7256
    PDF: 4046
    HTML: 24961
  • NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES

    Francesco D'Alò, Mariangela Greco, Marianna Criscuolo, Maria Teresa Voso
    e2010021
    2010-08-11
    https://doi.org/10.4084/mjhid.2010.021
    2041
    PDF: 1328
    HTML: 792
  • Acquired Hemophilia A successfully treated with rituximab

    Giovanni D'Arena, Elvira Grandone, Matteo Nicola Dario Di Minno, Pellegrino Musto, Giovanni Di Minno
    e2015024
    2015-02-17
    https://doi.org/10.4084/mjhid.2015.024
    2158
    PDF: 1176
    HTML: 1491
    Figure 1: 205
  • HYDROXYCARBAMINE: FROM AN OLD DRUG USED IN MALIGNANT HEMOPATHIES TO A CURRENT STANDARD IN SICKLE CELL DISEASE

    Giovanna Cannas, Solene Poutrel, Xavier Thomas
    e2017015
    2017-02-15
    https://doi.org/10.4084/mjhid.2017.015
    4019
    PDF: 1204
    HTML: 1828
  • RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: CHEMOIMMUNOTHERAPY, TREATMENT UNTIL PROGRESSION WITH MECHANISM-DRIVEN AGENTS OR FINITE-DURATION THERAPY?

    Antonio Cuneo, Robin Foà
    e2019024
    2019-02-27
    https://doi.org/10.4084/mjhid.2019.024
    2774
    PDF: 1692
    HTML: 388
  • SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML

    Francesco D'Alò, Luana Fianchi, Emiliano Fabiani, Marianna Criscuolo, Mariangela Greco, Francesco Guidi, Livio Pagano, Giuseppe Leone, Maria Teresa Voso
    e2011052
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.052
    3747
    PDF: 924
    HTML: 6861
  • THE ICET-A RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF DISTURBANCES OF GLUCOSE HOMEOSTASIS IN THALASSEMIA MAJOR PATIENTS

    Vincenzo De Sanctis
    e2016058
    2016-10-25
    https://doi.org/10.4084/mjhid.2016.058
    4295
    PDF: 1242
    HTML: 1314
  • Effect of Immunoglobulin Therapy on the Rate of Infections in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation and or Treated with Immunomodulatory Agents

    Alhossain A. Khalafallah, Matthias Maiwald, Amanda Cox, Burns Denise, Gerald Bates, Terry Hannan, David Seaton, Bernadene Fernandopulle, Terry Brain
    e2010005
    2010-04-20
    https://doi.org/10.4084/mjhid.2010.005
    1192
    PDF: 582
    HTML: 1186
  • Guest Editor: Pellegrino Musto AN UPDATE OF THE APPROPRIATE SEQUENCING FOR SALVAGE THERAPIES IN MULTIPLE MYELOMA

    Gregorio Barila', Francesca Rezzonico, Laura Pavan, Alessandro Corso, Renato Zambello
    e2025043
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.043
    1232
    PDF: 985
    HTML: 213
  • How I treat acute and persistent sickle cell pain

    Samir Ballas
    e2020064
    2020-09-08
    https://doi.org/10.4084/mjhid.2020.064
    2033
    PDF: 1144
    HTML: 648
  • INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY

    Giuseppe Leone, Livio Pagano
    e2018039
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.039
    4381
    PDF: 1478
    HTML: 705
  • BISPHOSPHONATES IN LANGERHANS CELL HISTIOCYTOSIS: AN INTERNATIONAL RETROSPECTIVE CASE SERIES

    Deepak Chellapandian, Polyzois Makras, Gregory Kaltsas, Cor van den Bos, Lamia Naccache, Raajit Rampal, Anne-Sophie Carret, Sheila Weitzman, R. Maarten Egeler, Oussama Abla
    e2016033
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.033
    3790
    PDF: 1271
    HTML: 1075
  • REAL WORLD MULTIPLE MYELOMA REGISTRY FROM JORDAN, A DEVELOPING COUNTRY.

    Abdalla Awidi, Farah Qasem, A'sem Abu-Qamar, Batool Aqel, Rand Aladayleh, Ilham Alteerah, Ahmad Magableh, , Hisham Bawa”neh, Feras Al-fararjeh
    e2022031
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.031
    1354
    PDF: 774
    HTML: 413
  • PHYSICIAN’S ATTITUDE TOWARDS TREATMENT OF OLDER PATIENTS AND THE CHOICE OF THERAPY

    Felicetto Ferrara
    e2013025
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.025
    2418
    PDF: 817
    HTML: 1963
  • THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

    Elvira Pelosi, Dr. Germana Castelli, Ugo Testa
    e2022080
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.080
    1586
    PDF: 1204
    HTML: 536
  • TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES

    Luis Anibarro, Alberto Pena
    e2014026
    2014-04-06
    https://doi.org/10.4084/mjhid.2014.026
    3382
    PDF: 1277
    HTML: 8386
  • Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.

    Dina Khalaf, Bassem Toema, Nidal Dabbour, Fathi Jehani
    e2011004
    2011-01-04
    https://doi.org/10.4084/mjhid.2011.004
    1827
    PDF: 568
    HTML: 16989
    Figure 4: 184
    Figure 3: 156
    Figure 2: 163
    Figure 1: 197
  • TREATMENT OF CANCER IN THE OLDER AGED PERSON

    Lodovico Balducci
    e2010029
    2010-10-01
    https://doi.org/10.4084/mjhid.2010.029
    1230
    PDF: 859
    HTML: 3413
  • HEMATOPOIETIC STEM CELL TRANSPLANTATION IN EGYPT CHALLENGES AND OPPORTUNITIES

    Hossam Kamel Mahmoud, Gamaleldin Mohamed Fathy, Alaa Elhaddad, Omar Abdelrahman Fahmy, Mohamed Abdelmooti, Raafat Abdelfattah, Mahmoud Tarek Sayed Ahmed Bokhary
    e2020023
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.023
    1915
    PDF: 1005
    HTML: 866
  • PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Isidro Jarque, Miguel Salavert, Javier Pemán
    e2016035
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.035
    3772
    PDF: 1276
    HTML: 3917
    Untitled: 248
    Untitled: 282
  • CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA

    Luca Castagna, Carmelo Carlo-Stella, Rita Mazza, Armando Santoro
    e2015015
    2015-02-12
    https://doi.org/10.4084/mjhid.2015.015
    2856
    PDF: 1443
    HTML: 4661
  • THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition

    Emiliano Fabiani, Dr. Falconi, Dr. Cristiano, Dr. Hajrullaj, Dr. Falconi, Prof. Leone, Prof. Voso
    e2023064
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.064
    1439
    PDF: 892
    HTML: 230
  • COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

    Federico Mercolini, Simone Cesaro
    e2022009
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.009
    2600
    PDF: 966
    HTML: 556
  • Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever

    Maria Grazia Massaro, Maurizio Pompili, Ludovico Luca Sicignano, Fabrizio Pizzolante, Elena Verrecchia, Fabio Maria Vecchio, Donato Rigante, Raffaele Manna
    e20200059
    2020-08-29
    https://doi.org/10.4084/mjhid.2020.059
    1424
    PDF: 940
    HTML: 421
  • PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID

    Francesco Rodeghiero
    e2021032
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.032
    2753
    PDF: 975
    HTML: 621
  • The COST-UTILITY ANALYSIS OF FOUR CHELATION REGIMENS FOR ?-THALASSEMIA MAJOR: A CHINESE PERSPECTIVE

    Jialian Li
    e2020029
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.029
    1915
    PDF: 994
    HTML: 346
  • NATION-WIDE SURVEY ON THE USE OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RA) FOR THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA IN CURRENT CLINICAL PRACTICE IN ITALY

    Francesco Rodeghiero, Dr. Mariasanta Napolitano, Nicola Vianelli, Lisanna Ghiotto, Silvia Cantoni, Giuseppe Carli, Monica Carpenedo, Valentina Carrai, Ugo Consoli, Gaetano Giuffrida, Elisa Lucchini, Elena Rossi, Cristina Santoro
    e2023019
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.019
    2406
    PDF: 1269
    PDF Appendix: 751
    HTML: 505
  • SURVEILLANCE AND CONTROL OF ANTIBIOTIC RESISTANCE IN THE MEDITERRANEAN REGION

    Walter Ricciardi, Gabriele Giubbini, Patrizia Laurenti
    e2016036
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.036
    4197
    PDF: 1419
    HTML: 13475
  • Management of pediatric rheumatological diseases during the outbreak of COVID-19: our experience

    Romina Gallizzi, Diana Sutera, Francesca Mazza, Alessandra Spagnolo, Giovanni Battista Pajno
    e2020049
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.049
    1125
    PDF: 770
    HTML: 230
  • DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.

    Maria Concetta Postorino, Filippo Luciani, Carmelo Mangano, Maria Stella Carpentieri, Paolo Scerbo, Armando Priamo, Giuseppina Berardelli, Roberto Marino, Alfredo Vallone, Nicola Serrao, Vincenzo Pisani, Chiara Costa, Albano Terremoto, Giuseppe Foti, Lucio Cosco, Massimo Calderazzo, Domenico Corigliano, Preziosa Scordo, Carlo Torti, Alessio Strazzulla
    e2015054
    2015-10-08
    https://doi.org/10.4084/mjhid.2015.054
    1651
    PDF: 834
    HTML: 1275
    Figure 1: 187
    Figure 2: 201
    Figure 3: 198
  • TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment

    Alessandro Buonomo, Eleonora Nucera, Marianna Criscuolo
    e2022040
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.040
    2190
    PDF: 1590
    HTML: 650
  • THE EVOLVING PHARMACOTHERAPEUTIC LANDSCAPE FOR THE TREATMENT OF SICKLE CELL DISEASE

    Samir Ballas
    e2020010
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.010
    3233
    PDF: 3086
    HTML: 1190
  • MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT

    Alfredo Marzano
    e2009025
    https://doi.org/10.4084/mjhid.2009.025
    878
    PDF: 493
    HTML: 1310
  • 5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature

    Mariangela Greco, Marianna Criscuolo, Luana Fianchi, Livio Pagano, Maria Teresa Voso
    e2011011
    2011-03-14
    https://doi.org/10.4084/mjhid.2011.011
    1662
    PDF: 787
    HTML: 1124
  • CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY

    Maria Ilaria Del Principe, Luca Maurillo, Francesco Buccisano, Giuseppe Sconocchia, Mariagiovanna Cefalo, Giovanna De Santis, Ambra Di Veroli, Concetta Ditto, Daniela Nasso, Massimiliano Postorino, Marco Refrigeri, Cristina Attrotto, Giovanni Del Poeta, Sergio Amadori, Adriano Venditti
    e2014075
    2014-11-01
    https://doi.org/10.4084/mjhid.2014.075
    4258
    PDF: 1976
    HTML: 5498
    Table 1: 226
  • CLASSICAL HODGKIN LYMPHOMA TODAY

    Francesco D'Alò, Gabriele Schiaffini, Daniele Mazzoni, Eleonora Alma, Flaminia Bellisario, Marcello Viscovo, Elena Maiolo, Silvia Bellesi, Stefan Hohaus
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.055
    647
    PDF: 418
    HTML: 163
  • BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES

    Giuseppe Leone, Eligio Pizzigallo
    e2015057
    2015-10-12
    https://doi.org/10.4084/mjhid.2015.057
    5035
    PDF: 2022
    HTML: 8686
  • “Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency. Hemolysis by Hemolysis and G6PD deficiency.

    NICOLA SGHERZA, Lidia Dalfino, Antonio Palma, Angelantonio Vitucci, Daniela Campanale, Salvatore Grasso, Pellegrino Musto
    e2020076
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.076
    1675
    PDF: 1018
    HTML: 376
  • HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?

    Antoine Thyss, Esma Saada, Lauris Gastaud, Frédéric Peyrade, Daniel Ré
    e2014050
    2014-07-01
    https://doi.org/10.4084/mjhid.2014.050
    2977
    PDF: 1399
    HTML: 3719
    Untitled: 208
    Untitled: 221
    Untitled: 195
  • ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THERAPY-RELATED MYELOID NEOPLASMS (t-MN) OF THE ADULT: MONOCENTRIC OBSERVATIONAL STUDY AND REVIEW OF THE LITERATURE.

    Elisabetta Metafuni, Patrizia Chiusolo, Luca Laurenti, Federica Sorà, Sabrina Giammarco, Andrea Bacigalupo, Giuseppe Leone, Simona Sica
    e2018005
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.005
    4257
    PDF: 1118
    HTML: 1446
  • SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY

    Francesco Ricci
    e2012048
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.048
    6222
    PDF: 3418
    HTML: 9052
    Figure Malaria Ricci: 244
  • OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION

    Rafael Rojas, José R. Molina, Isidro Jarque, Miguel A. Sanz
    e2012011
    2012-02-10
    https://doi.org/10.4084/mjhid.2012.011
    1182
    PDF: 560
    HTML: 1703
    Figures: 183
    Fifures Sanz: 190
    tables Sanz: 192
    Untitled: 188
  • Chemotherapy-colchicine interaction in a child with Familial Mediterranean Fever and Hodgkin Lymphoma

    Karin Petra Sabine Langenberg-Ververgaert, Ronald M. Laxer, Angela S. Punnett, Lee L Dupuis, Yaron Finkelstein, Oussama Abla
    e2018019
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.019
    2916
    PDF: 862
    HTML: 460
51 - 100 of 493 items << < 1 2 3 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.